跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUPEMTEK TETRA SOLUCION INYECTABLE EN JERINGA PRECARGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SUPEMTEK TETRA SOLUCION INYECTABLE EN JERINGA PRECARGADA
Approved
STANDARD
SUPEMTEK TETRA SOLUCION INYECTABLE EN JERINGA PRECARGADA
Sanofi Winthrop Industrie
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 1, 2021
Approval ID
88bc807d5a1fe2d4
Company
Sanofi Winthrop Industrie
Type
Standard
Approval Details
Approval Id
88bc807d5a1fe2d4
Drug Cima Aemps Name
SUPEMTEK TETRA SOLUCION INYECTABLE EN JERINGA PRECARGADA
Register Number
1201484001
Holder Company Name
Sanofi Winthrop Industrie
Marketing Company Name
Sanofi Aventis S.A.
Holder Company Detail Path
/organization/sanofi-winthrop-industrie
Authorization Date
2021-02-01
Dosage Form
SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA
Dose
45 microgram/dose of Influenza A virus subtype H1N1 haemagglutinin, recombinant - REVISAR µg HA
Route Of Administration
VÍA INTRAMUSCULAR
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Sanofi Winthrop Industrie
Company Detail Path
/organization/sanofi-winthrop-industrie
Company Information
Pharmaceutical Company Name
SANOFI WINTHROP INDUSTRIE
Country Name
France
City Name
amilly,centre val de loire,country_fr
Address
130 RUE DE LA FONTAINE
Active Ingredients
VIRUS GRIPE A H1N1 RECOMBINANTE HEMAGLUTININA
45 microgramos/ml
VIRUS GRIPE A H3N2 RECOMBINANTE HEMAGLUTININA
45 microgramos/ml
VIRUS GRIPE B (VICTORIA) RECOMBINANTE
45 microgramos/ml
VIRUS GRIPE B (YAMAGATA) RECOMBINANTE
45 microgramos/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 1, 2021
Approval ID
88bc807d5a1fe2d4
Type
Standard
Back to CIMA-AEMPS Approvals